nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP2C19—Cholecalciferol—osteoporosis	0.0837	0.143	CbGbCtD
Pentobarbital—CYP3A4—Estropipate—osteoporosis	0.0785	0.134	CbGbCtD
Pentobarbital—CYP3A4—Calcitriol—osteoporosis	0.0785	0.134	CbGbCtD
Pentobarbital—CYP2C19—Estradiol—osteoporosis	0.0675	0.115	CbGbCtD
Pentobarbital—CYP3A4—Ergocalciferol—osteoporosis	0.0628	0.107	CbGbCtD
Pentobarbital—CYP3A4—Raloxifene—osteoporosis	0.0524	0.0897	CbGbCtD
Pentobarbital—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0506	0.0866	CbGbCtD
Pentobarbital—CYP3A4—Cholecalciferol—osteoporosis	0.0405	0.0693	CbGbCtD
Pentobarbital—CYP3A4—Conjugated Estrogens—osteoporosis	0.0371	0.0636	CbGbCtD
Pentobarbital—CYP3A4—Estradiol—osteoporosis	0.0326	0.0558	CbGbCtD
Pentobarbital—Depressed level of consciousness—Calcium Acetate—osteoporosis	0.0133	0.0321	CcSEcCtD
Pentobarbital—Injection site reaction—Ibandronate—osteoporosis	0.00745	0.018	CcSEcCtD
Pentobarbital—Bradycardia—Calcium Acetate—osteoporosis	0.00703	0.017	CcSEcCtD
Pentobarbital—Syncope—Calcium Acetate—osteoporosis	0.00539	0.013	CcSEcCtD
Pentobarbital—Injection site reaction—Zoledronate—osteoporosis	0.00533	0.0129	CcSEcCtD
Pentobarbital—Loss of consciousness—Calcium Acetate—osteoporosis	0.00528	0.0128	CcSEcCtD
Pentobarbital—Confusional state—Calcium Acetate—osteoporosis	0.00495	0.012	CcSEcCtD
Pentobarbital—Shock—Calcium Acetate—osteoporosis	0.00483	0.0117	CcSEcCtD
Pentobarbital—Hypotension—Calcium Acetate—osteoporosis	0.00459	0.0111	CcSEcCtD
Pentobarbital—Hallucination—Etidronic acid—osteoporosis	0.00451	0.0109	CcSEcCtD
Pentobarbital—Constipation—Calcium Acetate—osteoporosis	0.0042	0.0101	CcSEcCtD
Pentobarbital—Feeling abnormal—Calcium Acetate—osteoporosis	0.00404	0.00978	CcSEcCtD
Pentobarbital—Constipation—Ergocalciferol—osteoporosis	0.00371	0.00897	CcSEcCtD
Pentobarbital—Hypersensitivity—Calcium Acetate—osteoporosis	0.00362	0.00874	CcSEcCtD
Pentobarbital—Angioedema—Etidronic acid—osteoporosis	0.00361	0.00872	CcSEcCtD
Pentobarbital—Tension—Estropipate—osteoporosis	0.00335	0.0081	CcSEcCtD
Pentobarbital—Nervousness—Estropipate—osteoporosis	0.00332	0.00802	CcSEcCtD
Pentobarbital—Confusional state—Etidronic acid—osteoporosis	0.00325	0.00786	CcSEcCtD
Pentobarbital—Dizziness—Calcium Acetate—osteoporosis	0.00325	0.00785	CcSEcCtD
Pentobarbital—Angioedema—Estropipate—osteoporosis	0.00312	0.00755	CcSEcCtD
Pentobarbital—Vomiting—Calcium Acetate—osteoporosis	0.00312	0.00755	CcSEcCtD
Pentobarbital—Angioedema—Alendronate—osteoporosis	0.00307	0.00743	CcSEcCtD
Pentobarbital—Angioedema—Ibandronate—osteoporosis	0.00299	0.00724	CcSEcCtD
Pentobarbital—Syncope—Raloxifene—osteoporosis	0.00297	0.00717	CcSEcCtD
Pentobarbital—Agitation—Calcitriol—osteoporosis	0.00295	0.00713	CcSEcCtD
Pentobarbital—Nausea—Calcium Acetate—osteoporosis	0.00291	0.00705	CcSEcCtD
Pentobarbital—Loss of consciousness—Raloxifene—osteoporosis	0.00291	0.00703	CcSEcCtD
Pentobarbital—Anxiety—Estropipate—osteoporosis	0.0029	0.00701	CcSEcCtD
Pentobarbital—Anxiety—Ibandronate—osteoporosis	0.00278	0.00672	CcSEcCtD
Pentobarbital—Constipation—Etidronic acid—osteoporosis	0.00275	0.00666	CcSEcCtD
Pentobarbital—Bradycardia—Zoledronate—osteoporosis	0.00274	0.00663	CcSEcCtD
Pentobarbital—Anxiety—Calcitriol—osteoporosis	0.00272	0.00658	CcSEcCtD
Pentobarbital—Shock—Raloxifene—osteoporosis	0.00266	0.00642	CcSEcCtD
Pentobarbital—Feeling abnormal—Etidronic acid—osteoporosis	0.00265	0.00642	CcSEcCtD
Pentobarbital—Shock—Ibandronate—osteoporosis	0.00263	0.00636	CcSEcCtD
Pentobarbital—Nausea—Ergocalciferol—osteoporosis	0.00257	0.00623	CcSEcCtD
Pentobarbital—Angioedema—Ethinyl Estradiol—osteoporosis	0.00253	0.00612	CcSEcCtD
Pentobarbital—Tension—Pamidronate—osteoporosis	0.00252	0.00609	CcSEcCtD
Pentobarbital—Nervousness—Pamidronate—osteoporosis	0.00249	0.00603	CcSEcCtD
Pentobarbital—Somnolence—Estropipate—osteoporosis	0.00248	0.00599	CcSEcCtD
Pentobarbital—Angioedema—Risedronate—osteoporosis	0.00247	0.00596	CcSEcCtD
Pentobarbital—Syncope—Risedronate—osteoporosis	0.00242	0.00585	CcSEcCtD
Pentobarbital—Constipation—Estropipate—osteoporosis	0.00238	0.00576	CcSEcCtD
Pentobarbital—Hypersensitivity—Etidronic acid—osteoporosis	0.00237	0.00574	CcSEcCtD
Pentobarbital—Loss of consciousness—Risedronate—osteoporosis	0.00237	0.00574	CcSEcCtD
Pentobarbital—Agitation—Pamidronate—osteoporosis	0.00236	0.0057	CcSEcCtD
Pentobarbital—Anxiety—Ethinyl Estradiol—osteoporosis	0.00235	0.00568	CcSEcCtD
Pentobarbital—Constipation—Alendronate—osteoporosis	0.00235	0.00568	CcSEcCtD
Pentobarbital—Angioedema—Pamidronate—osteoporosis	0.00234	0.00567	CcSEcCtD
Pentobarbital—Somnolence—Calcitriol—osteoporosis	0.00233	0.00563	CcSEcCtD
Pentobarbital—Syncope—Pamidronate—osteoporosis	0.0023	0.00556	CcSEcCtD
Pentobarbital—Anxiety—Risedronate—osteoporosis	0.00229	0.00554	CcSEcCtD
Pentobarbital—Constipation—Ibandronate—osteoporosis	0.00229	0.00553	CcSEcCtD
Pentobarbital—Feeling abnormal—Alendronate—osteoporosis	0.00226	0.00547	CcSEcCtD
Pentobarbital—Loss of consciousness—Pamidronate—osteoporosis	0.00225	0.00545	CcSEcCtD
Pentobarbital—Constipation—Calcitriol—osteoporosis	0.00224	0.00541	CcSEcCtD
Pentobarbital—Tension—Conjugated Estrogens—osteoporosis	0.00221	0.00536	CcSEcCtD
Pentobarbital—Body temperature increased—Estropipate—osteoporosis	0.0022	0.00533	CcSEcCtD
Pentobarbital—Feeling abnormal—Ibandronate—osteoporosis	0.0022	0.00533	CcSEcCtD
Pentobarbital—Nervousness—Conjugated Estrogens—osteoporosis	0.00219	0.0053	CcSEcCtD
Pentobarbital—Anxiety—Pamidronate—osteoporosis	0.00218	0.00526	CcSEcCtD
Pentobarbital—Body temperature increased—Alendronate—osteoporosis	0.00217	0.00525	CcSEcCtD
Pentobarbital—Shock—Risedronate—osteoporosis	0.00217	0.00524	CcSEcCtD
Pentobarbital—Agitation—Zoledronate—osteoporosis	0.00215	0.00521	CcSEcCtD
Pentobarbital—Angioedema—Zoledronate—osteoporosis	0.00214	0.00518	CcSEcCtD
Pentobarbital—Body temperature increased—Raloxifene—osteoporosis	0.00213	0.00516	CcSEcCtD
Pentobarbital—Body temperature increased—Ibandronate—osteoporosis	0.00211	0.00511	CcSEcCtD
Pentobarbital—Confusional state—Pamidronate—osteoporosis	0.00211	0.00511	CcSEcCtD
Pentobarbital—Syncope—Zoledronate—osteoporosis	0.0021	0.00508	CcSEcCtD
Pentobarbital—Body temperature increased—Calcitriol—osteoporosis	0.00207	0.005	CcSEcCtD
Pentobarbital—Angioedema—Conjugated Estrogens—osteoporosis	0.00206	0.00499	CcSEcCtD
Pentobarbital—Shock—Pamidronate—osteoporosis	0.00206	0.00498	CcSEcCtD
Pentobarbital—Loss of consciousness—Zoledronate—osteoporosis	0.00206	0.00498	CcSEcCtD
Pentobarbital—Hypersensitivity—Estropipate—osteoporosis	0.00205	0.00497	CcSEcCtD
Pentobarbital—Vomiting—Etidronic acid—osteoporosis	0.00205	0.00495	CcSEcCtD
Pentobarbital—Rash—Etidronic acid—osteoporosis	0.00203	0.00491	CcSEcCtD
Pentobarbital—Dermatitis—Etidronic acid—osteoporosis	0.00203	0.00491	CcSEcCtD
Pentobarbital—Syncope—Conjugated Estrogens—osteoporosis	0.00202	0.00489	CcSEcCtD
Pentobarbital—Hypersensitivity—Alendronate—osteoporosis	0.00202	0.00489	CcSEcCtD
Pentobarbital—Headache—Etidronic acid—osteoporosis	0.00202	0.00488	CcSEcCtD
Pentobarbital—Anxiety—Zoledronate—osteoporosis	0.00199	0.00481	CcSEcCtD
Pentobarbital—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00198	0.0048	CcSEcCtD
Pentobarbital—Hypersensitivity—Ibandronate—osteoporosis	0.00197	0.00476	CcSEcCtD
Pentobarbital—Hypotension—Pamidronate—osteoporosis	0.00196	0.00473	CcSEcCtD
Pentobarbital—Constipation—Ethinyl Estradiol—osteoporosis	0.00193	0.00467	CcSEcCtD
Pentobarbital—Confusional state—Zoledronate—osteoporosis	0.00193	0.00466	CcSEcCtD
Pentobarbital—Hypersensitivity—Calcitriol—osteoporosis	0.00193	0.00466	CcSEcCtD
Pentobarbital—Anxiety—Conjugated Estrogens—osteoporosis	0.00191	0.00463	CcSEcCtD
Pentobarbital—Nausea—Etidronic acid—osteoporosis	0.00191	0.00463	CcSEcCtD
Pentobarbital—Constipation—Risedronate—osteoporosis	0.00188	0.00456	CcSEcCtD
Pentobarbital—Shock—Zoledronate—osteoporosis	0.00188	0.00455	CcSEcCtD
Pentobarbital—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00186	0.0045	CcSEcCtD
Pentobarbital—Somnolence—Pamidronate—osteoporosis	0.00186	0.0045	CcSEcCtD
Pentobarbital—Dizziness—Estropipate—osteoporosis	0.00184	0.00446	CcSEcCtD
Pentobarbital—Dizziness—Alendronate—osteoporosis	0.00182	0.00439	CcSEcCtD
Pentobarbital—Shock—Conjugated Estrogens—osteoporosis	0.00181	0.00438	CcSEcCtD
Pentobarbital—Constipation—Pamidronate—osteoporosis	0.00179	0.00433	CcSEcCtD
Pentobarbital—Hypotension—Zoledronate—osteoporosis	0.00179	0.00432	CcSEcCtD
Pentobarbital—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00179	0.00432	CcSEcCtD
Pentobarbital—Dizziness—Raloxifene—osteoporosis	0.00179	0.00432	CcSEcCtD
Pentobarbital—Tension—Estradiol—osteoporosis	0.00177	0.00429	CcSEcCtD
Pentobarbital—Vomiting—Estropipate—osteoporosis	0.00177	0.00429	CcSEcCtD
Pentobarbital—Dizziness—Ibandronate—osteoporosis	0.00177	0.00427	CcSEcCtD
Pentobarbital—Rash—Estropipate—osteoporosis	0.00176	0.00425	CcSEcCtD
Pentobarbital—Dermatitis—Estropipate—osteoporosis	0.00176	0.00425	CcSEcCtD
Pentobarbital—Nervousness—Estradiol—osteoporosis	0.00175	0.00424	CcSEcCtD
Pentobarbital—Headache—Estropipate—osteoporosis	0.00175	0.00422	CcSEcCtD
Pentobarbital—Vomiting—Alendronate—osteoporosis	0.00175	0.00422	CcSEcCtD
Pentobarbital—Body temperature increased—Risedronate—osteoporosis	0.00174	0.00421	CcSEcCtD
Pentobarbital—Rash—Alendronate—osteoporosis	0.00173	0.00419	CcSEcCtD
Pentobarbital—Dermatitis—Alendronate—osteoporosis	0.00173	0.00418	CcSEcCtD
Pentobarbital—Feeling abnormal—Pamidronate—osteoporosis	0.00173	0.00417	CcSEcCtD
Pentobarbital—Hypotension—Conjugated Estrogens—osteoporosis	0.00172	0.00416	CcSEcCtD
Pentobarbital—Headache—Alendronate—osteoporosis	0.00172	0.00416	CcSEcCtD
Pentobarbital—Vomiting—Raloxifene—osteoporosis	0.00172	0.00415	CcSEcCtD
Pentobarbital—Rash—Raloxifene—osteoporosis	0.0017	0.00412	CcSEcCtD
Pentobarbital—Dermatitis—Raloxifene—osteoporosis	0.0017	0.00411	CcSEcCtD
Pentobarbital—Somnolence—Zoledronate—osteoporosis	0.0017	0.00411	CcSEcCtD
Pentobarbital—Vomiting—Ibandronate—osteoporosis	0.0017	0.00411	CcSEcCtD
Pentobarbital—Headache—Raloxifene—osteoporosis	0.00169	0.00409	CcSEcCtD
Pentobarbital—Rash—Ibandronate—osteoporosis	0.00169	0.00408	CcSEcCtD
Pentobarbital—Dermatitis—Ibandronate—osteoporosis	0.00168	0.00407	CcSEcCtD
Pentobarbital—Headache—Ibandronate—osteoporosis	0.00167	0.00405	CcSEcCtD
Pentobarbital—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00166	0.00403	CcSEcCtD
Pentobarbital—Vomiting—Calcitriol—osteoporosis	0.00166	0.00402	CcSEcCtD
Pentobarbital—Agitation—Estradiol—osteoporosis	0.00166	0.00401	CcSEcCtD
Pentobarbital—Nausea—Estropipate—osteoporosis	0.00166	0.004	CcSEcCtD
Pentobarbital—Body temperature increased—Pamidronate—osteoporosis	0.00166	0.004	CcSEcCtD
Pentobarbital—Angioedema—Estradiol—osteoporosis	0.00165	0.00399	CcSEcCtD
Pentobarbital—Rash—Calcitriol—osteoporosis	0.00165	0.00399	CcSEcCtD
Pentobarbital—Dermatitis—Calcitriol—osteoporosis	0.00165	0.00399	CcSEcCtD
Pentobarbital—Headache—Calcitriol—osteoporosis	0.00164	0.00396	CcSEcCtD
Pentobarbital—Somnolence—Conjugated Estrogens—osteoporosis	0.00164	0.00396	CcSEcCtD
Pentobarbital—Constipation—Zoledronate—osteoporosis	0.00164	0.00396	CcSEcCtD
Pentobarbital—Nausea—Alendronate—osteoporosis	0.00163	0.00394	CcSEcCtD
Pentobarbital—Hypersensitivity—Risedronate—osteoporosis	0.00162	0.00392	CcSEcCtD
Pentobarbital—Syncope—Estradiol—osteoporosis	0.00162	0.00392	CcSEcCtD
Pentobarbital—Nausea—Raloxifene—osteoporosis	0.0016	0.00388	CcSEcCtD
Pentobarbital—Nausea—Ibandronate—osteoporosis	0.00159	0.00384	CcSEcCtD
Pentobarbital—Loss of consciousness—Estradiol—osteoporosis	0.00159	0.00384	CcSEcCtD
Pentobarbital—Feeling abnormal—Zoledronate—osteoporosis	0.00158	0.00381	CcSEcCtD
Pentobarbital—Constipation—Conjugated Estrogens—osteoporosis	0.00157	0.00381	CcSEcCtD
Pentobarbital—Nausea—Calcitriol—osteoporosis	0.00155	0.00376	CcSEcCtD
Pentobarbital—Hypersensitivity—Pamidronate—osteoporosis	0.00154	0.00373	CcSEcCtD
Pentobarbital—Anxiety—Estradiol—osteoporosis	0.00153	0.00371	CcSEcCtD
Pentobarbital—Body temperature increased—Zoledronate—osteoporosis	0.00151	0.00366	CcSEcCtD
Pentobarbital—Dizziness—Ethinyl Estradiol—osteoporosis	0.00149	0.00361	CcSEcCtD
Pentobarbital—Confusional state—Estradiol—osteoporosis	0.00149	0.00359	CcSEcCtD
Pentobarbital—Dizziness—Risedronate—osteoporosis	0.00146	0.00352	CcSEcCtD
Pentobarbital—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00146	0.00352	CcSEcCtD
Pentobarbital—Shock—Estradiol—osteoporosis	0.00145	0.00351	CcSEcCtD
Pentobarbital—Vomiting—Ethinyl Estradiol—osteoporosis	0.00144	0.00347	CcSEcCtD
Pentobarbital—Rash—Ethinyl Estradiol—osteoporosis	0.00142	0.00345	CcSEcCtD
Pentobarbital—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00142	0.00344	CcSEcCtD
Pentobarbital—Headache—Ethinyl Estradiol—osteoporosis	0.00142	0.00342	CcSEcCtD
Pentobarbital—Hypersensitivity—Zoledronate—osteoporosis	0.00141	0.00341	CcSEcCtD
Pentobarbital—Vomiting—Risedronate—osteoporosis	0.0014	0.00339	CcSEcCtD
Pentobarbital—Rash—Risedronate—osteoporosis	0.00139	0.00336	CcSEcCtD
Pentobarbital—Dermatitis—Risedronate—osteoporosis	0.00139	0.00336	CcSEcCtD
Pentobarbital—Dizziness—Pamidronate—osteoporosis	0.00138	0.00335	CcSEcCtD
Pentobarbital—Headache—Risedronate—osteoporosis	0.00138	0.00334	CcSEcCtD
Pentobarbital—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00136	0.00328	CcSEcCtD
Pentobarbital—Nausea—Ethinyl Estradiol—osteoporosis	0.00134	0.00325	CcSEcCtD
Pentobarbital—Vomiting—Pamidronate—osteoporosis	0.00133	0.00322	CcSEcCtD
Pentobarbital—Rash—Pamidronate—osteoporosis	0.00132	0.00319	CcSEcCtD
Pentobarbital—Dermatitis—Pamidronate—osteoporosis	0.00132	0.00319	CcSEcCtD
Pentobarbital—Headache—Pamidronate—osteoporosis	0.00131	0.00317	CcSEcCtD
Pentobarbital—Somnolence—Estradiol—osteoporosis	0.00131	0.00317	CcSEcCtD
Pentobarbital—Nausea—Risedronate—osteoporosis	0.00131	0.00316	CcSEcCtD
Pentobarbital—Dizziness—Zoledronate—osteoporosis	0.00126	0.00306	CcSEcCtD
Pentobarbital—Constipation—Estradiol—osteoporosis	0.00126	0.00305	CcSEcCtD
Pentobarbital—Nausea—Pamidronate—osteoporosis	0.00124	0.00301	CcSEcCtD
Pentobarbital—Dizziness—Conjugated Estrogens—osteoporosis	0.00122	0.00295	CcSEcCtD
Pentobarbital—Vomiting—Zoledronate—osteoporosis	0.00122	0.00294	CcSEcCtD
Pentobarbital—Feeling abnormal—Estradiol—osteoporosis	0.00121	0.00294	CcSEcCtD
Pentobarbital—Rash—Zoledronate—osteoporosis	0.00121	0.00292	CcSEcCtD
Pentobarbital—Dermatitis—Zoledronate—osteoporosis	0.0012	0.00291	CcSEcCtD
Pentobarbital—Headache—Zoledronate—osteoporosis	0.0012	0.0029	CcSEcCtD
Pentobarbital—Vomiting—Conjugated Estrogens—osteoporosis	0.00117	0.00283	CcSEcCtD
Pentobarbital—Body temperature increased—Estradiol—osteoporosis	0.00117	0.00282	CcSEcCtD
Pentobarbital—Rash—Conjugated Estrogens—osteoporosis	0.00116	0.00281	CcSEcCtD
Pentobarbital—Dermatitis—Conjugated Estrogens—osteoporosis	0.00116	0.00281	CcSEcCtD
Pentobarbital—Headache—Conjugated Estrogens—osteoporosis	0.00115	0.00279	CcSEcCtD
Pentobarbital—Nausea—Zoledronate—osteoporosis	0.00114	0.00275	CcSEcCtD
Pentobarbital—Nausea—Conjugated Estrogens—osteoporosis	0.00109	0.00265	CcSEcCtD
Pentobarbital—Hypersensitivity—Estradiol—osteoporosis	0.00109	0.00263	CcSEcCtD
Pentobarbital—Dizziness—Estradiol—osteoporosis	0.000975	0.00236	CcSEcCtD
Pentobarbital—Vomiting—Estradiol—osteoporosis	0.000937	0.00227	CcSEcCtD
Pentobarbital—Rash—Estradiol—osteoporosis	0.000929	0.00225	CcSEcCtD
Pentobarbital—Dermatitis—Estradiol—osteoporosis	0.000928	0.00225	CcSEcCtD
Pentobarbital—Headache—Estradiol—osteoporosis	0.000923	0.00223	CcSEcCtD
Pentobarbital—Nausea—Estradiol—osteoporosis	0.000875	0.00212	CcSEcCtD
Pentobarbital—GRIA2—N-cadherin signaling events—GSN—osteoporosis	0.000144	0.059	CbGpPWpGaD
Pentobarbital—GRIA2—N-cadherin signaling events—LRP5—osteoporosis	0.000125	0.0513	CbGpPWpGaD
Pentobarbital—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	9.97e-05	0.0409	CbGpPWpGaD
Pentobarbital—GABRA6—Orphan transporters—ANXA2—osteoporosis	4.18e-05	0.0171	CbGpPWpGaD
Pentobarbital—GABRA4—Orphan transporters—ANXA2—osteoporosis	4.12e-05	0.0169	CbGpPWpGaD
Pentobarbital—GABRB2—Orphan transporters—ANXA2—osteoporosis	3.77e-05	0.0155	CbGpPWpGaD
Pentobarbital—GABRA5—Orphan transporters—ANXA2—osteoporosis	3.66e-05	0.015	CbGpPWpGaD
Pentobarbital—GABRA3—Orphan transporters—ANXA2—osteoporosis	3.6e-05	0.0148	CbGpPWpGaD
Pentobarbital—GABRA2—Orphan transporters—ANXA2—osteoporosis	3.54e-05	0.0145	CbGpPWpGaD
Pentobarbital—GABRB3—Orphan transporters—ANXA2—osteoporosis	3.51e-05	0.0144	CbGpPWpGaD
Pentobarbital—GABRG2—Orphan transporters—ANXA2—osteoporosis	3.45e-05	0.0141	CbGpPWpGaD
Pentobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	3.45e-05	0.0141	CbGpPWpGaD
Pentobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	3.4e-05	0.014	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—GAPDH—osteoporosis	3.15e-05	0.0129	CbGpPWpGaD
Pentobarbital—GABRA1—Orphan transporters—ANXA2—osteoporosis	3.01e-05	0.0124	CbGpPWpGaD
Pentobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	2.8e-05	0.0115	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—RAP1A—osteoporosis	2.75e-05	0.0113	CbGpPWpGaD
Pentobarbital—GABRA6—GABA receptor activation—ADCY5—osteoporosis	2.69e-05	0.011	CbGpPWpGaD
Pentobarbital—GABRA4—GABA receptor activation—ADCY5—osteoporosis	2.65e-05	0.0109	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—ALPL—osteoporosis	2.64e-05	0.0108	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—GAPDH—osteoporosis	2.57e-05	0.0105	CbGpPWpGaD
Pentobarbital—GABRB2—GABA receptor activation—ADCY5—osteoporosis	2.43e-05	0.00995	CbGpPWpGaD
Pentobarbital—GABRA5—GABA receptor activation—ADCY5—osteoporosis	2.36e-05	0.00966	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—BMP2—osteoporosis	2.32e-05	0.00951	CbGpPWpGaD
Pentobarbital—GABRA3—GABA receptor activation—ADCY5—osteoporosis	2.31e-05	0.00949	CbGpPWpGaD
Pentobarbital—GABRA2—GABA receptor activation—ADCY5—osteoporosis	2.27e-05	0.00933	CbGpPWpGaD
Pentobarbital—GABRB3—GABA receptor activation—ADCY5—osteoporosis	2.26e-05	0.00926	CbGpPWpGaD
Pentobarbital—GABRG2—GABA receptor activation—ADCY5—osteoporosis	2.22e-05	0.0091	CbGpPWpGaD
Pentobarbital—CYP2A6—Fluoropyrimidine Activity—MTHFR—osteoporosis	2.2e-05	0.00901	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—ESR2—osteoporosis	2.18e-05	0.00895	CbGpPWpGaD
Pentobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	2.1e-05	0.00862	CbGpPWpGaD
Pentobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	2.07e-05	0.00851	CbGpPWpGaD
Pentobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.94e-05	0.00796	CbGpPWpGaD
Pentobarbital—GABRA1—GABA receptor activation—ADCY5—osteoporosis	1.94e-05	0.00795	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—RAP1A—osteoporosis	1.92e-05	0.00789	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—ALPL—osteoporosis	1.85e-05	0.00757	CbGpPWpGaD
Pentobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.81e-05	0.00743	CbGpPWpGaD
Pentobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.79e-05	0.00733	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—ESR2—osteoporosis	1.78e-05	0.0073	CbGpPWpGaD
Pentobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.77e-05	0.00724	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	1.7e-05	0.00699	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—BMP2—osteoporosis	1.62e-05	0.00665	CbGpPWpGaD
Pentobarbital—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	1.59e-05	0.00653	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	1.59e-05	0.00652	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—CYP27A1—osteoporosis	1.49e-05	0.00609	CbGpPWpGaD
Pentobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.48e-05	0.00609	CbGpPWpGaD
Pentobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.47e-05	0.00602	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.46e-05	0.00599	CbGpPWpGaD
Pentobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.44e-05	0.00591	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—SPP1—osteoporosis	1.4e-05	0.00576	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.33e-05	0.00545	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—IRS2—osteoporosis	1.27e-05	0.00521	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	1.26e-05	0.00518	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	1.25e-05	0.00512	CbGpPWpGaD
Pentobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.24e-05	0.00506	CbGpPWpGaD
Pentobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.22e-05	0.005	CbGpPWpGaD
Pentobarbital—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	1.19e-05	0.00489	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6R—osteoporosis	1.16e-05	0.00477	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—ADCY5—osteoporosis	1.12e-05	0.00459	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.12e-05	0.00458	CbGpPWpGaD
Pentobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.12e-05	0.00457	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—IRS1—osteoporosis	1.11e-05	0.00455	CbGpPWpGaD
Pentobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.1e-05	0.00453	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—ESR2—osteoporosis	1.1e-05	0.00452	CbGpPWpGaD
Pentobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.09e-05	0.00447	CbGpPWpGaD
Pentobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.09e-05	0.00446	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.08e-05	0.00444	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.08e-05	0.00444	CbGpPWpGaD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.06e-05	0.00436	CbGpPWpGaD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.05e-05	0.00429	CbGpPWpGaD
Pentobarbital—CYP2C19—Arachidonic acid metabolism—GPX1—osteoporosis	1.04e-05	0.00427	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.04e-05	0.00426	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	1.02e-05	0.0042	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	1.02e-05	0.00418	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.02e-05	0.00418	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—ADCY5—osteoporosis	1.02e-05	0.00417	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.01e-05	0.00413	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—SPP1—osteoporosis	9.83e-06	0.00403	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6R—osteoporosis	9.48e-06	0.00389	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—ADCY5—osteoporosis	9.28e-06	0.00381	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ANXA2—osteoporosis	9.21e-06	0.00378	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—ADCY5—osteoporosis	9.17e-06	0.00376	CbGpPWpGaD
Pentobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	9.14e-06	0.00375	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	9.05e-06	0.00371	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.95e-06	0.00367	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.94e-06	0.00367	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	8.93e-06	0.00366	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	8.92e-06	0.00366	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—IRS2—osteoporosis	8.89e-06	0.00364	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—osteoporosis	8.84e-06	0.00363	CbGpPWpGaD
Pentobarbital—CYP2A6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.83e-06	0.00362	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.78e-06	0.0036	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.63e-06	0.00354	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.57e-06	0.00352	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—ADCY5—osteoporosis	8.55e-06	0.00351	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.42e-06	0.00345	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—ADCY5—osteoporosis	8.38e-06	0.00344	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—ADCY5—osteoporosis	8.3e-06	0.0034	CbGpPWpGaD
Pentobarbital—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	8.21e-06	0.00337	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—ADCY5—osteoporosis	8.15e-06	0.00334	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—ADCY5—osteoporosis	8e-06	0.00328	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—ADCY5—osteoporosis	7.86e-06	0.00322	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—ADCY5—osteoporosis	7.81e-06	0.0032	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—CYP19A1—osteoporosis	7.8e-06	0.0032	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—IRS1—osteoporosis	7.76e-06	0.00318	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—ADCY5—osteoporosis	7.67e-06	0.00314	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.36e-06	0.00302	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—AGER—osteoporosis	7.29e-06	0.00299	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—osteoporosis	7.21e-06	0.00296	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—ADCY5—osteoporosis	7.11e-06	0.00292	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—ADCY5—osteoporosis	7.02e-06	0.00288	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—ADCY5—osteoporosis	6.7e-06	0.00275	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	6.64e-06	0.00272	CbGpPWpGaD
Pentobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.64e-06	0.00272	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	6.55e-06	0.00269	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—ADCY5—osteoporosis	6.42e-06	0.00263	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—osteoporosis	6.42e-06	0.00263	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—ADCY5—osteoporosis	6.24e-06	0.00256	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—ADCY5—osteoporosis	6.13e-06	0.00251	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.05e-06	0.00248	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—ADCY5—osteoporosis	6.02e-06	0.00247	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—ADCY5—osteoporosis	5.98e-06	0.00245	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—ADCY5—osteoporosis	5.88e-06	0.00241	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL6R—osteoporosis	5.87e-06	0.00241	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.74e-06	0.00235	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	5.44e-06	0.00223	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	5.38e-06	0.00221	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.38e-06	0.00221	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	5.37e-06	0.0022	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—osteoporosis	5.23e-06	0.00214	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—osteoporosis	5.18e-06	0.00212	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—ADCY5—osteoporosis	5.14e-06	0.00211	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	4.76e-06	0.00195	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	4.69e-06	0.00192	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—POMC—osteoporosis	4.69e-06	0.00192	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—osteoporosis	4.46e-06	0.00183	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.46e-06	0.00183	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PKM—osteoporosis	4.42e-06	0.00181	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—FDPS—osteoporosis	4.42e-06	0.00181	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.35e-06	0.00178	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—osteoporosis	4.22e-06	0.00173	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PGLS—osteoporosis	4.19e-06	0.00172	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GPD2—osteoporosis	4.19e-06	0.00172	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.99e-06	0.00164	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ATIC—osteoporosis	3.83e-06	0.00157	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PNP—osteoporosis	3.83e-06	0.00157	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.82e-06	0.00157	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.78e-06	0.00155	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.48e-06	0.00143	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.45e-06	0.00142	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.36e-06	0.00138	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.29e-06	0.00135	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—OXCT1—osteoporosis	3.26e-06	0.00134	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CA2—osteoporosis	3.26e-06	0.00134	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—osteoporosis	3.24e-06	0.00133	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.24e-06	0.00133	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.24e-06	0.00133	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.22e-06	0.00132	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MGLL—osteoporosis	3.18e-06	0.0013	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.16e-06	0.0013	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	3.08e-06	0.00126	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.96e-06	0.00121	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.86e-06	0.00117	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—POMC—osteoporosis	2.86e-06	0.00117	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.82e-06	0.00116	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.76e-06	0.00113	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—IDH2—osteoporosis	2.7e-06	0.00111	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PKM—osteoporosis	2.7e-06	0.00111	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—FDPS—osteoporosis	2.7e-06	0.00111	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—osteoporosis	2.61e-06	0.00107	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PGLS—osteoporosis	2.56e-06	0.00105	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPD2—osteoporosis	2.56e-06	0.00105	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP27A1—osteoporosis	2.54e-06	0.00104	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ACP5—osteoporosis	2.47e-06	0.00101	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PNP—osteoporosis	2.34e-06	0.000958	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ATIC—osteoporosis	2.34e-06	0.000958	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TPI1—osteoporosis	2.3e-06	0.000942	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—P4HB—osteoporosis	2.16e-06	0.000885	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GAPDH—osteoporosis	2.12e-06	0.000869	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—RAP1A—osteoporosis	2.06e-06	0.000846	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CA2—osteoporosis	1.99e-06	0.000815	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—OXCT1—osteoporosis	1.99e-06	0.000815	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MGLL—osteoporosis	1.94e-06	0.000794	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.83e-06	0.000749	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—POMC—osteoporosis	1.72e-06	0.000705	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ENO1—osteoporosis	1.67e-06	0.000684	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—IDH2—osteoporosis	1.65e-06	0.000675	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PSMA5—osteoporosis	1.64e-06	0.000674	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PSMA2—osteoporosis	1.64e-06	0.000674	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—FDPS—osteoporosis	1.62e-06	0.000665	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PKM—osteoporosis	1.62e-06	0.000665	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.55e-06	0.000635	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PGLS—osteoporosis	1.54e-06	0.00063	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPD2—osteoporosis	1.54e-06	0.00063	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ACP5—osteoporosis	1.51e-06	0.000618	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.49e-06	0.00061	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ATIC—osteoporosis	1.41e-06	0.000576	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PNP—osteoporosis	1.41e-06	0.000576	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TPI1—osteoporosis	1.4e-06	0.000574	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP19A1—osteoporosis	1.33e-06	0.000547	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—P4HB—osteoporosis	1.32e-06	0.00054	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GAPDH—osteoporosis	1.29e-06	0.00053	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—RAP1A—osteoporosis	1.26e-06	0.000516	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CA2—osteoporosis	1.2e-06	0.00049	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—OXCT1—osteoporosis	1.2e-06	0.00049	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MGLL—osteoporosis	1.16e-06	0.000478	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.1e-06	0.00045	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ADCY5—osteoporosis	1.09e-06	0.000447	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GPX1—osteoporosis	1.09e-06	0.000445	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ENO1—osteoporosis	1.02e-06	0.000417	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PSMA2—osteoporosis	1e-06	0.000411	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PSMA5—osteoporosis	1e-06	0.000411	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTHFR—osteoporosis	1e-06	0.000411	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—IDH2—osteoporosis	9.9e-07	0.000406	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP27A1—osteoporosis	9.31e-07	0.000382	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ACP5—osteoporosis	9.06e-07	0.000371	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TPI1—osteoporosis	8.42e-07	0.000345	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP19A1—osteoporosis	8.13e-07	0.000334	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—POMC—osteoporosis	8.02e-07	0.000329	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—P4HB—osteoporosis	7.92e-07	0.000325	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GAPDH—osteoporosis	7.77e-07	0.000319	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—RAP1A—osteoporosis	7.57e-07	0.00031	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ADCY5—osteoporosis	6.65e-07	0.000273	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPX1—osteoporosis	6.62e-07	0.000272	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ENO1—osteoporosis	6.12e-07	0.000251	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTHFR—osteoporosis	6.11e-07	0.000251	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PSMA5—osteoporosis	6.03e-07	0.000247	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PSMA2—osteoporosis	6.03e-07	0.000247	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.89e-07	0.000201	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—POMC—osteoporosis	4.89e-07	0.0002	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ADCY5—osteoporosis	4e-07	0.000164	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPX1—osteoporosis	3.98e-07	0.000163	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTHFR—osteoporosis	3.68e-07	0.000151	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—POMC—osteoporosis	2.94e-07	0.000121	CbGpPWpGaD
